KFDA seeking to reclassify 17 prescription drugs

Published: 2011-07-21 06:57:00

Updated: 2011-07-21 06:57:00

The Korea Food and Drug Administration’s attempt to permit sales of prescription drugs without prescription was crushed Tuesday as representatives of pharmacists and doctors failed to reach an agreement.

Instead, the KFDA said that the subcommittee of the Central Pharmaceutical Affairs Council...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK